Страница клинических исследований Nct
Clinical Trial Results:
DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ON THE USE OF ACETYL-L-CARNITINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
| Summary | |
EudraCT number | 2004-004158-23 |
Trial protocol | IT |
Global completion date | 01 Feb 2011 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 17 Feb 2019 |
First version publication date | 17 Feb 2019 |
Other versions | |
Summary report(s) | Publication study ALC in patients with ALS |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.